针对血液性恶性瘤的辐射:从细胞杀伤到免疫细胞原始化
Bouthaina Dabaja1, Michael Spiotto1
1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Frontiers in oncology
|June 29, 2023
概括
放射治疗正在从直接的癌细胞杀手演变为血液恶性瘤的免疫系统刺激剂. 将辐射与免疫疗法结合起来可以增强抗瘤反应,并可能使无需化疗的治疗成为可能.
科学领域:
- 癌症免疫学 癌症免疫学
- 辐射疗法 辐射疗法
- 血液学的恶性瘤
背景情况:
- 放射治疗的作用正在转向免疫反应刺激.
- 了解血液癌症中的放射治疗-免疫相互作用正在出现.
- 本综述侧重于免疫疗法和用于血液癌症的采用细胞疗法的最新进展.
研究的目的:
- 审查最近免疫疗法和用于血液性恶性瘤的采用细胞疗法的进展.
- 突出证据支持放射治疗和免疫治疗的整合.
- 解释放射治疗如何刺激和增强抗瘤免疫反应.
主要方法:
- 关于放射治疗,免疫治疗和血液恶性瘤的当前文献的综述.
- 对结合放射治疗和免疫疗法的证据分析.
- 讨论放射治疗在促进采用细胞疗法的作用,例如CAR T细胞.
主要成果:
- 放射治疗可以与免疫治疗相结合,以增强抗瘤免疫力.
- 放射治疗作为改善CAR T细胞植入和活动的桥梁.
- 将放射疗法与免疫疗法相结合可能导致无化疗治疗方案.
结论:
- 放射治疗启动抗瘤免疫反应,增强免疫疗法和采用细胞疗法.
- 放射治疗在血液性恶性瘤中的新用途正在出现,因为它具有免疫性潜力.
- 放射治疗和免疫治疗的整合为治疗血液癌症提供了一个有前途的途径.
相关概念视频
Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Cytotoxic T Cells-mediated Immune Response
995
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
995
Cell-mediated Immune Responses
69.1K
Overview
69.1K


